Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
361 hedge funds and large institutions have $7.31B invested in Abiomed Inc in 2017 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 126 increasing their positions, 127 reducing their positions, and 23 closing their positions.
187% more first-time investments, than exits
New positions opened: 66 | Existing positions closed: 23
14% more funds holding
Funds holding: 318 → 361 (+43)
7% more capital invested
Capital invested by funds: $6.84B → $7.31B (+$469M)
1% less repeat investments, than reductions
Existing positions increased: 126 | Existing positions reduced: 127
24% less call options, than puts
Call options by funds: $32M | Put options by funds: $42.3M
40% less funds holding in top 10
Funds holding in top 10: 10 → 6 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
+$89.5M |
| 2 |
MWNA
Marshall Wace North America
New York
|
+$64.7M |
| 3 |
PA
Perceptive Advisors
New York
|
+$30.5M |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$24.5M |
| 5 |
Morgan Stanley
New York
|
+$23.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$87.7M |
| 2 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$76.4M |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$65.3M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$64.6M |
| 5 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
-$56M |
ABMD Hedge Fund Activity: Q4 2017 in Review
361 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2017, worth a combined $7.31B — up 6.9% from $6.84B a quarter earlier.
Buyers outnumbered sellers: 66 funds opened new ABMD positions and 23 closed out — a net gain of 43 holders — while 126 added to existing stakes and 127 trimmed.
The largest buyer was American Century Companies, adding an estimated $89.5M. The largest seller was Janus Henderson Group, cutting an estimated $87.7M.
- 361 institutional investors held Abiomed Inc (ABMD) as of Q4 2017, up from 318 in Q3 2017.
- Funds reported $7.31B of Abiomed Inc stock for Q4 2017, up 6.9% quarter-over-quarter.
- 66 funds opened new Abiomed Inc positions in Q4 2017 and 23 closed out, a net change of +43 holders.
- The largest Abiomed Inc buyer in Q4 2017 was American Century Companies, an estimated $89.5M added.
- The largest Abiomed Inc seller in Q4 2017 was Janus Henderson Group, an estimated $87.7M sold.
Based on aggregated 13F filings for Q4 2017.